AU4448700A - Suppression of transformation of cells by the transcription factor egr - Google Patents
Suppression of transformation of cells by the transcription factor egrInfo
- Publication number
- AU4448700A AU4448700A AU44487/00A AU4448700A AU4448700A AU 4448700 A AU4448700 A AU 4448700A AU 44487/00 A AU44487/00 A AU 44487/00A AU 4448700 A AU4448700 A AU 4448700A AU 4448700 A AU4448700 A AU 4448700A
- Authority
- AU
- Australia
- Prior art keywords
- suppression
- transformation
- cells
- transcription factor
- factor egr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11891299P | 1999-02-05 | 1999-02-05 | |
US60118912 | 1999-02-05 | ||
PCT/US2000/002799 WO2000045771A2 (fr) | 1999-02-05 | 2000-02-04 | Suppression de la transformation de cellules par le facteur de transcription egr |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4448700A true AU4448700A (en) | 2000-08-25 |
Family
ID=22381501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44487/00A Abandoned AU4448700A (en) | 1999-02-05 | 2000-02-04 | Suppression of transformation of cells by the transcription factor egr |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4448700A (fr) |
WO (1) | WO2000045771A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030394A1 (fr) * | 1999-10-26 | 2001-05-03 | Unisearch Limited | Traitement du cancer |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
US7981415B2 (en) | 2007-09-07 | 2011-07-19 | Cisthera, Inc. | Humanized PAI-1 antibodies |
EP2198055A4 (fr) | 2007-09-07 | 2012-04-18 | Cisthera Inc | Anticorps pai-1 humanisés |
CN110408691A (zh) * | 2019-08-09 | 2019-11-05 | 福建医科大学孟超肝胆医院(福州市传染病医院) | 与预测肝移植术后排斥反应相关的标志物egr-1及其应用 |
CN114588264B (zh) * | 2022-02-25 | 2023-05-16 | 上海大学 | 敲低或抑制egr3的试剂在制备心肌缺血再灌注损伤药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837692A (en) * | 1994-04-07 | 1998-11-17 | Mercola; Dan | Inhibition of the mitogenic activity of PDGF by mammalian EGr |
-
2000
- 2000-02-04 AU AU44487/00A patent/AU4448700A/en not_active Abandoned
- 2000-02-04 WO PCT/US2000/002799 patent/WO2000045771A2/fr active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030394A1 (fr) * | 1999-10-26 | 2001-05-03 | Unisearch Limited | Traitement du cancer |
Also Published As
Publication number | Publication date |
---|---|
WO2000045771A3 (fr) | 2000-12-07 |
WO2000045771A9 (fr) | 2001-09-20 |
WO2000045771A2 (fr) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1803601A (en) | Methods and compositions for the introduction of molecules into cells | |
EP1180015B8 (fr) | Generation de micromousse therapeutique | |
AU2741801A (en) | Splittable medical valve | |
AU3867400A (en) | Methods of using bioelastomers | |
AU5024000A (en) | Moru/be multilayers | |
AU2961300A (en) | Flush-mount pivoting speaker | |
AU6864600A (en) | Fuel cell | |
AU5003600A (en) | Charged membrane | |
AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
AU6400500A (en) | Pedestal closure assembly | |
AU5756200A (en) | Filter tower structure | |
EP1113701A3 (fr) | Microphone à pression différentielle | |
AU1853400A (en) | Topical anesthesia of the urinary bladder | |
AU4448700A (en) | Suppression of transformation of cells by the transcription factor egr | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU6299800A (en) | Turbocharger | |
AU1540101A (en) | Distortion reduction | |
AU2201501A (en) | Structure | |
AU2001236755A1 (en) | Structures and methods for improved capacitor cells | |
AU2001239311A1 (en) | Novel imidazole derivatives with anti-inflammatory activity | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU3805400A (en) | Utilization of tricyclodecandimethanol for producing multilayer lacquers | |
AU5313500A (en) | Transcription factors related to tfiia | |
AU6947200A (en) | Hybrid transformer | |
AU4010000A (en) | Epimerization reaction for the production of r-fluoxetine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |